Viatris (VTRS) Divestments (2021 - 2025)
Viatris' (VTRS) quarterly Divestments came in at $2.5 million in Q4 2025, up 180.65% year-on-year from $890804.6 in Q4 2024, and up 180.65% quarter-over-quarter from -$3.1 million in Q4 2024.
Viatris (VTRS) Divestments (2021 - 2025) Analysis & Trends
Viatris' Divestments history runs 5 years deep, the most recent figure standing at $2.5 million for Q4 2025.
- On a quarterly basis, Divestments rose 180.65% year-over-year to $2.5 million in Q4 2025; TTM through Dec 2025 was $2.5 million, a 99.9% decrease from a year earlier, with the FY2025 full-year figure at $2.5 million, down 99.9% from the prior year.
- Divestments improved to $2.5 million in Q4 2025 per VTRS's latest filing, from -$3.1 million in the prior quarter.
- Across five years, Divestments topped out at $2.0 billion in Q4 2022 and bottomed at -$3.1 million in Q4 2024.
- The 5-year median for Divestments is $144.3 million (2023), against an average of $483.7 million.
- Across the five-year window, Divestments soared 974900.0% in 2022 and sank 100.98% in 2024, its largest moves.
- Year by year, Divestments stood at $200000.0 in 2021, then surged by 974900.0% to $2.0 billion in 2022, then tumbled by 83.79% to $316.1 million in 2023, then plunged by 100.98% to -$3.1 million in 2024, then soared by 180.65% to $2.5 million in 2025.
- Per Business Quant, the three latest VTRS Divestments figures stand at $2.5 million (Q4 2025), -$3.1 million (Q4 2024), and $1.8 billion (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 42.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.28 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 63.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.50 Mn |
| Dec 31, 2024 | -3.10 Mn |
| Sep 30, 2024 | 1.83 Bn |
| Jun 30, 2024 | 437.10 Mn |
| Mar 31, 2024 | 240.60 Mn |
| Dec 31, 2023 | 316.10 Mn |
| Sep 30, 2023 | 48.00 Mn |
| Dec 31, 2022 | 1.95 Bn |
| Dec 31, 2021 | 200,000.00 |
| Sep 30, 2021 | 13.10 Mn |